Active Ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form; Route of Administration: FILM; BUCCAL, SUBLINGUAL
Strength: EQ 8MG BASE;EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212756
Product Number: 001
Approval Date: Jun 2, 2022
Applicant Holder Full Name: AVEVA DRUG DELIVERY SYSTEMS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form; Route of Administration: FILM; BUCCAL, SUBLINGUAL
Strength: EQ 12MG BASE;EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212756
Product Number: 002
Approval Date: Jun 2, 2022
Applicant Holder Full Name: AVEVA DRUG DELIVERY SYSTEMS INC
Marketing Status:
Prescription
Patent and Exclusivity Information